Cytokine

Papers
(The H4-Index of Cytokine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Interleukin-8: An evolving chemokine193
Cytokine profile and disease severity in patients with COVID-19150
Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine117
Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19117
Role of IL-6 in the regulation of neuronal development, survival and function88
Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review81
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-1967
SARS-CoV-2 triggering autoimmune diseases66
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?65
Effect of ginger (Zingiber officinale) on inflammatory markers: A systematic review and meta-analysis of randomized controlled trials62
The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-1957
The regenerative mechanisms of platelet-rich plasma: A review57
Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients56
The impact of COVID-19 infection on the cytokine profile of pregnant women: A prospective case-control study56
Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations56
G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation53
Role of IL-6 in the commitment of T cell subsets52
LncRNA MEG3 suppresses PI3K/AKT/mTOR signalling pathway to enhance autophagy and inhibit inflammation in TNF-α-treated keratinocytes and psoriatic mice52
Glycyrrhizin prevents SARS-CoV-2 S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication50
Interleukin-15 in autoimmunity49
Influences of the IL-6 cytokine family on bone structure and function48
A primer on cytokines44
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, an44
Emerging roles for IL-11 in inflammatory diseases43
Altered Th17/Treg ratio as a possible mechanism in pathogenesis of idiopathic membranous nephropathy42
Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose–response meta-analysis of randomized controlled trials41
Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions40
Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer39
Effect of curcumin on proinflammatory cytokines: A meta-analysis of randomized controlled trials39
TGF-beta signaling in cancer radiotherapy38
The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-1937
A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus37
Phloridzin attenuates lipopolysaccharide-induced cognitive impairment via antioxidant, anti-inflammatory and neuromodulatory activities37
Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus37
Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt//β-catenin signal pathway37
Serum interleukin-6 in schizophrenia: A system review and meta-analysis36
Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress36
Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review36
0.038743019104004